BusinessGrowth Expected for the 2017 Megaputer Analytics ConferenceBy Nasdaq OMXAug 30, 2017, 9:05 PM UTC
BusinessExosome Diagnostics Launches the MedOncAlyzer™ Pan-Cancer PanelBy Nasdaq OMXAug 9, 2017, 1:02 PM UTC
BusinessGlobal Membrane Technology In Pharma, Biopharma And Life Science Market Is Expected To Boost, Driven By Rise In Membrane Technology In Food And Drug IndustriesBy Nasdaq OMXAug 9, 2017, 11:47 AM UTC
BusinessEarth Science Tech, Inc. Signs Contract with Absolu to Advance Phase-2 Rollout on MSN-2 Medical DeviceBy Nasdaq OMXAug 3, 2017, 12:35 PM UTC
BusinessEarth Science Tech Inc. Signs Contract with CDBQ to Advance Phase-2 Rollout on it’s CBD PatentsBy Nasdaq OMXAug 1, 2017, 12:25 PM UTC
BusinessEarth Science Tech, Inc. Receives a Price Target of $4.12 from Leading Independent Equity Research & Corporate Firm, SeeThruEquityBy Nasdaq OMXJun 29, 2017, 12:45 PM UTC
BusinessEarth Science Tech, Inc. Launches Earth Science Pharmaceutical & MSN-2 Medical Device Websites, Adds Michel Gauthier M.D. to the Advisory Board, and Reports Over 80% Profit IncreaseBy Nasdaq OMXJun 19, 2017, 12:15 PM UTC
